Hypothesis and Theory
Accepted on 26 Feb 2025
A syringeable immunotherapeutic hydrogel enhances T cell immunity via in-situ activation of STING pathway for advanced breast cancer postoperative therapy
in Cancer Immunity and Immunotherapy
Hypothesis and Theory
Accepted on 26 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 26 Feb 2025
in Petrology
Original Research
Accepted on 26 Feb 2025
in Animal Nutrition
Original Research
Accepted on 26 Feb 2025
in Human-Media Interaction
Original Research
Accepted on 26 Feb 2025
in Organizational Psychology
Hypothesis and Theory
Accepted on 26 Feb 2025
in Biogeography and Macroecology
Original Research
Accepted on 26 Feb 2025
in Machine Learning and Artificial Intelligence
Original Research
Accepted on 26 Feb 2025
in Adolescent and Young Adult Psychiatry
Review
Accepted on 26 Feb 2025
in Smart Technologies and Cities
Original Research
Accepted on 26 Feb 2025
in Urban Science
Editorial
Accepted on 26 Feb 2025
in Aging Psychiatry
Original Research
Accepted on 26 Feb 2025
in Petrology
Original Research
Accepted on 26 Feb 2025
in Neurodegeneration
Review
Accepted on 26 Feb 2025
in Inflammation
Editorial
Accepted on 26 Feb 2025
in Pediatric Oncology
Review
Accepted on 26 Feb 2025
in Cancer Immunity and Immunotherapy